Persistent Hair Thinning?
Explore New Treatment Options for Androgenetic Alopecia!
Androgenetic Alopecia (AGA), is a progressive hair loss condition that affects nearly half of men and women and often leads to gradual thinning of the hair or baldness over time. It is primarily driven by genetic factors and hormonal changes, leading to thinning hair on the crown, a receding hairline, and overall hair loss progression.
At Revival Research Institute, we are conducting Androgenetic Alopecia Clinical Trial to explore potential treatment options that may help slow hair loss and promote regrowth. Participating in this research study could contribute to advancing hair loss treatments and provide new hope for individuals experiencing AGA.
To participate in the Androgenetic Alopecia clinical trials, you must meet these criteria:
- Subject is a male or female, 18 – 65 years old
- Suffering hair loss in the temple region or the top of the head
We are conducting phase 3 clinical trials for hair loss in men. This could be the breakthrough we need to fight against hair loss.
*To participate in the androgenetic alopecia clinical trials, please fill out the form, and someone from our research team will give you a call.
**The study drug and study-related care will be provided at no cost. No insurance is required to participate.

